Zogenix (ZGNX) Tops Q3 EPS by 27c

Zogenix (NASDAQ: ZGNX) reported Q3 EPS of ($0.69), $0.27 better than the analyst estimate of ($0.96). Revenue for the quarter came in at $6.6 million versus the consensus estimate of $3.1 million.

For earnings history and earnings-related data on Zogenix (ZGNX) click here.

You May Also Be Interested In

• Jefferies sees a buying opportunity in this S&P 500 sector
• Wolfe Research upgrades Biogen, AbbVie on pipeline strength and valuation
• Candel Therapeutics, Inc. (CADL) Misses Q2 EPS by 29c